Patents by Inventor Thomas Prod'homme

Thomas Prod'homme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230221302
    Abstract: Described herein are methods for treating rheumatoid arthritis by determining whether a subject having rheumatoid arthritis will respond to an anti-TNF-alpha therapy based on the number of innate and adaptive immune cells in a sample from the subject prior to treatment.
    Type: Application
    Filed: March 21, 2023
    Publication date: July 13, 2023
    Inventors: Ishan Capila, Victor Farutin, Thomas Prod'homme, Kevin McConnell, Leona Ling
  • Patent number: 11639923
    Abstract: Described herein are methods for treating rheumatoid arthritis by determining whether a subject having rheumatoid arthritis will respond to an anti-TNF-alpha therapy based on the number of innate and adaptive immune cells in a sample from the subject prior to treatment.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: May 2, 2023
    Assignee: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Ishan Capila, Victor Farutin, Thomas Prod'homme, Kevin McConnell, Leona Ling
  • Publication number: 20200256851
    Abstract: Described herein are methods for treating rheumatoid arthritis by determining whether a subject having rheumatoid arthritis will respond to an anti-TNF-alpha therapy based on the number of innate and adaptive immune cells in a sample from the subject prior to treatment.
    Type: Application
    Filed: September 18, 2018
    Publication date: August 13, 2020
    Inventors: Ishan Capila, Victor Farutin, Thomas Prod'homme, Kevin McConnell, Leona Ling